COVID-19 Severity in Multiple SclerosisMaria Pia Sormani, Giovanna Borriello, Paolo Immovilli et al.|Neurology Neuroimmunology & Neuroinflammation|2021Cited by 74
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational studyDamiano Baroncini, Angelo Ghezzi, Mauro Zaffaroni et al.|Multiple Sclerosis Journal|2018Cited by 62
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control studyMarta Ponzano, Viola Baione, Irene Schiavetti et al.|Multiple Sclerosis and Related Disorders|2022Cited by 10